Buparvaquone is a hydroxynaphthoquinone antiprotozoal agent used primarily for the therapy and prophylaxis of theileriosis in cattle. As a member of the atovaquone drug class, it functions by inhibiting… Read more
Buparvaquone is a hydroxynaphthoquinone antiprotozoal agent used primarily for the therapy and prophylaxis of theileriosis in cattle. As a member of the atovaquone drug class, it functions by inhibiting the mitochondrial electron transport chain in parasites, effectively disrupting their energy metabolism. To support the rigorous demands of pharmaceutical research and development, laboratories utilize a range of Buparvaquone-related materials for analytical testing and quality control. This category includes high-quality reference standards of the active pharmaceutical ingredient (API), which are essential for method validation, stability studies, and impurity profiling. Additionally, the availability of known pharmacopeial and non-pharmacopeial impurities, as well as stable isotope labelled compounds, facilitates accurate quantitative analysis and the identification of unknown substances in complex matrices. These tools are critical for ensuring consistency, safety, and regulatory compliance throughout the drug development lifecycle and in subsequent manufacturing quality assurance.